Introduction {#sec1-1}
============

Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disease \[[@ref1]\], \[[@ref2]\]. Although many medicines are prescribed for the treatment of RA, they are known to produce various side effects. So, there is still a need to seek therapeutic agents with lower side effects that can be used for long-term administration \[[@ref3]\], \[[@ref4]\]. *Achyranthesaspera* belongs to the family Amaranthaceae; it is an annual shrub found distributed throughout the tropical and subtropical regions. In the recent past, there has been a tremendous increase in the use of plant-based health products in developing as well as developed countries resulting in an exponential growth of herbal products globally. It is commonly found in India, Baluchistan, Sri Lanka, tropical Asia, Africa, Australia, and America \[[@ref4]\], \[[@ref5]\], \[[@ref6]\]. Herbal drugs constitute a major part of all traditional systems of medicines \[[@ref5]\]. The plant is a popular folk remedy in traditional system of medicine throughout the tropical Asian and African countries. The World Health Organization has attempted to identify all medicinal plants used globally and listed more than 20,000 species \[[@ref6]\]. The plant is highly esteemed by traditional healers and used in treatment of asthma \[[@ref5]\], \[[@ref6]\], spermicidal activity \[[@ref7]\], post-coital antifertility activity \[[@ref8]\], anti-parasitic activity \[[@ref9]\], hypoglycaemic activity \[[@ref10]\], hepatoprotective activity \[[@ref11]\], anti-inflammatory \[[@ref12]\], nephroprotective \[[@ref13]\], anti-depressant \[[@ref14]\], bronchoprotective \[[@ref15]\], antiallergic \[[@ref16]\]. Hence, the present study is made for the evaluation of aqueous extract of AA for anti-arthritic activity in rats fed with formaldehyde. In this study, we assessed the effects of *Achyranthesaspera* against rheumatoid arthritis.

Material and Methods {#sec1-2}
====================

Collection and identification of the plant materials {#sec2-1}
----------------------------------------------------

The leaves of *Achyranthesaspera* collected from Tirumala Forest, Tirupathi, Chittoor District, Andhra Pradesh, India. Botanical identification was carried out at the Department of Botany, Sri Venkateswara University, Tirupathi. Where, voucher specimen No.SKCCP/2015/110a was deposited in the museum of the department of Pharmacognosy Sri Krishna Chaithanya College of pharmacy, Madanapalle, Andhra Pradesh, India

Drugs and Chemicals {#sec2-2}
-------------------

Serum kits were obtained from Span Diagnostics Ltd. Surat, India. Diclofenac sodium was supplied from Ajanta Pharma Limited, Maharashtra, India. Formaldehyde, purchased from Sigma Aldrich Chemical, India. Normal saline purchased from bio-aids scientific, Bangalore, India. All other chemicals were of analytical grade procured from reputed Indian manufacturers.

Experimental animals {#sec2-3}
--------------------

All the experiments were carried out using Swiss Albino mice (25-30 g) and Wister rats (150-180 g). The animals were placed at random and allocated to treatment groups in polypropylene cages with paddy husk as bedding. Animals were housed in a temperature of 24 ± 2°C and relative humidity of 30--70%. A 12 hrs day: 12 hrs night cycle was followed. All animals were allowed free access to water and fed. Ethical clearance was obtained from the Institutional Animal Ethical Committee (IAEC) of Sri Krishna Chaithanya College of Pharmacy, Madanapalle, Andhra Pradesh.

Preparation of the extracts {#sec2-4}
---------------------------

The collected leaves were dried completely and powder with a mechanical grinder. The powder was passed through sieve no. 60 to get uniform powdered. The 250 gm of dried powder of *Achyranthesaspera* leaves was defatted with Petroleum ether. The defatted powder material (marc) thus obtained was successively extracted with aqueous solvent by maceration. The Maceration process involves the separation of medicinally active portions of the crude drugs. The drug material is taken in a stoppered container and immersed in the bulk of the solvents in the ratio of 1: 2 (Drug & Solvent) and allowed to stand for 7 days in room temperature with frequent shaking of every 30 minutes up to 6 hours on each day. The solvent was separated by filtration and concentrated under reduced pressure. The resulting semisolid mass was vacuum dried, and the percentage yield was calculated \[[@ref17]\].

Acute toxicity study {#sec2-5}
--------------------

The acute toxicity study was carried out to extract of *Achyranthesaspera* as per OECD 423 Guidelines. Swiss albino mice with weight ranging (25-30 g) were taken for the experiment. The animals were made into a group of 3 each, dose of aqueous extract was given according to the bodyweight (mg/kg), starting dose of 5 mg/kg was given to the first group of animal, no death was occurring and higher doses were given to the next group of animals up to 5000 mg/kg. The animals were observed for a further 14 days for any signs for delayed toxicity \[[@ref18]\].

The time at which signs of toxicity appear/disappear was observed systematically and recorded for each animal.

Formaldehyde induced arthritis {#sec2-6}
------------------------------

Group 1: Normal control (1% v/v tween 80, p.o. for 28 days).

Group 2: Negative Control (Formaldehyde 0.1 ml 2% v/v by Sub-plantar region).

Group 3: Formaldehyde 0.1 ml 2% v/v + Standard (Diclofenac 10 mg/kg p.o. for 28 days).

Group 4: Formaldehyde 0.1 ml 2% v/v + Low dose of AEAA (125 mg/kg p.o. for 28 days).

Group 5: Formaldehyde 0.1 ml 2% v/v + Medium dose of AEAA (250 mg/kg p.o. for 28 days).

Group 6: Formaldehyde 0.1 ml 2% v/v + High dose of AEAA (500 mg/kg p.o. for 28 days).

Animals were divided into six groups (n = 6). Group I received the vehicle (2 ml/kg, 1% v/v tween 80) and served as the normal control. Group II received formaldehyde, served as a negative control. Group III received the standard drug diclofenac (10 mg/kg body weight), groups IV, V and VI received AEAA in doses of (125, 250 and 500 mg/kg body weight), respectively. Thirty minutes after oral administration of vehicle/drugs, arthritis was induced by subplantaradministration of 0.1 ml formaldehyde (2% v/v) into the left hind paw of all the animals except normal control. This was designated as day 1. Vehicle/drug treatment was continued for the duration of 28 more days. Formaldehyde (0.1 ml 2% v/v) was again injected into the same paw on the third day \[[@ref19]\], \[[@ref20]\].

Paw volume and paw thickness were measured at 0 days, 7th day, 14th day, 21st day and 28th day by using Plethysmometerand vernier calibre, respectively. The body weights of the animals were measured by digital balance to access the exact dose & course of the disease at the initial day after induction, 14^th^ day and the end of 28^th^ day.

\% inhibition of paw oedema concerning untreated groups was calculated using the following formula:

i= \[1-(∆V~treated~/∆V~untreated~)\]x 100

Where,

i= % inhibition of paw edema

∆V ~treated=\ mean\ change\ in\ paw\ volume\ of\ treated\ rat~

∆V ~untreated=\ mean\ change\ in\ paw\ volume\ of\ untreated\ rat~

Method for collection of a blood sample {#sec2-7}
---------------------------------------

On the 28^th^ day, the blood (2 ml) collected by retro-orbital cavity under the influence of ether anaesthesia. Some of the collected blood was used to perform Hematological studies to estimate Hb gm/dl, & ESR mm/hr. The remaining blood was used to centrifuge at 3000 rpm at room temperature, and collected serum was used to perform the RA factor.

Radiography {#sec2-8}
-----------

Radiographic evaluation was performed based on radiographs and coned down views of lower limbs. Radiographs were taken with GE 500 mA, 40 kvp and 4 MAS.

Histopathological analysis {#sec2-9}
--------------------------

A portion of the bones was immediately kept in 10% formalin to fix the tissue after isolation. The bones were washed in running tap water, decalcified by placing in formic acid and dehydrated in the descending grades of alcohol and finally cleared in xylene. The tissues were embedded in molten paraffin wax.

Hard paraffin wax was melted and poured into square-shaped blocks. The knee joints were then dropped into the liquid paraffin quickly and allowed to cool. The blocks were cut using microtome to get sections of thickness 10 µm. The section was dried completely before staining. Eosin an acidic stain and hematoxylin a basic stain was used for staining and observed under an electronic microscope for histopathological changes \[[@ref21]\].

Statistical analysis {#sec2-10}
--------------------

The statistical significance was assessed by using one-way analysis of variance (ANOVA) and followed by Dunnet\`s comparison test. All data are presented as mean ± SEM, and *p \< 0.01* was considered significant.

Results {#sec1-3}
=======

Preliminary phytochemical screening {#sec2-11}
-----------------------------------

The preliminary phytochemical analysis of aqueous extracts of *Achyranthesaspera* revealed the presence of Alkaloids, Carbohydrates, glycosides phenolic compound, flavonoids, tannin and proteins ([Table 1](#T1){ref-type="table"}).

###### 

Preliminary phytochemical screening of aqueous extract of Achyranthesaspera

  Sl. No   Constituents          Observation in AEAA
  -------- --------------------- ---------------------
  1\.      Alkaloids             Positive
  2\.      Carbohydrates         Positive
  3\.      Glycosides            Positive
  4\.      Phenolic compounds    Positive
  5\.      Flavonoids            Positive
  6\.      Tannin and Proteins   Positive

Blood and serum analysis {#sec2-12}
------------------------

As a result of inflammation induced by formaldehyde, the levels of Hb mg/dl & ESR mm/hr were increased in all arthritis rats as compared to negative control rats. After extract treatment, the levels of these haematological parameters were significant (p \< 0.01) decreased in group V &VI rats as compared to negative control rats except Group IV revealed non-significant.

The dose of 500 mg/kg aqueous extract-treated group prevented haematological changes to a greater extent than the Diclofenac sodium (10 mg/kg). However, treated groups III, V & VI serum show RA factor negative results as compared to the negative control, which shows positive. The group IV shows the RA factor positive, the group V & VI proving its anti-arthritic efficacy.

Effect of AEAA on joint swelling (paw volume) in formaldehyde induced arthritis {#sec2-13}
-------------------------------------------------------------------------------

An increase in paw volume was seen in all animals throughout the observation period. Maximum paw volume was observed on day 21, after which there was a gradual decrease except in the negative control and AEAA (125 mg/kg) treated groups, which showed an increase in paw volume from Day 1 to day 28.

Although drug-treated groups showed a decrease in joint swelling as compared to the negative control, the difference was significant (p \< 0.01) in Group III, V, VI on all observation day. AEAA at a dose of 125 mg/kg (Group IV) produced a nonsignificant reduction in paw volume on all observation day.

Radiological studies {#sec2-14}
--------------------

The radiographic features of the rat joints in formaldehyde induced arthritic model, as shown in [Figure 1](#F1){ref-type="fig"}. In formaldehyde induced arthritis rats (group II), soft tissue swelling along with a narrowing of the joint spaces were observed which implies the bony destruction in arthritic condition \[[@ref22]\]. The standard drug Diclofenac sodium treated groups have prevented this bony destruction and also there is decreased swelling of the joint. The AEAA 250 & 500 mg/kg treatment for 28 days have shown significant prevention against bony destruction by showing less soft tissue swelling and narrowing of joint spaces when compared with the negative control.

![Radiography of the rat joints in formaldehyde induced arthritic model; A) Normal Control (DMSO 2 ml/kg); B) Negative control; C) Standard (Diclofenac 10 mg/kg); D) AEAA 125 mg/kg; E) AEAA 250 mg/kg; F) AEAA 500 mg/kg](OAMJMS-7-2709-g001){#F1}

Effect of AEAA on joint diameter in formaldehyde induced arthritis {#sec2-15}
------------------------------------------------------------------

Administration of formaldehyde 0.1 ml 2% v/v produced an increase in the joint diameter of all the animals, which was persistent throughout the observation period ([Figure 2](#F2){ref-type="fig"}). Maximum joint swelling was observed on day 14, after which there was a gradual decrease except in the negative control and AEAA (125 mg/kg) treated groups, which showed an increase in joint diameter from Day 1 to day 28. At the highest dose (500 mg/kg), AEAA was more efficacious as equal to Diclofenac in reducing the joint swelling.

![Histological examination of experimental rats; A) Normal Control (DMSO 2 ml/kg); B) Negative control; C) Standard (Diclofenac 10 mg/kg); D) AEAA 125 mg/kg; E) AEAA 250 mg/kg; F) AEAA 500 mg/kg](OAMJMS-7-2709-g002){#F2}

Histopathological studies {#sec2-16}
-------------------------

Histological studies of ankle joint reports confirm that there is severe bone erosion with the presence of neutrophil infiltration and pannus formation in the negative control group, as shown in [Figure 2b](#F2){ref-type="fig"}. The treatment groups AEAA 250 mg/kg and 500 mg/kg revealed a reduction in pannus formation and bone resorption, joint inflammation with reduced neutrophil infiltration. Among the two-dose group, 500 mg/kg proved a dose-dependent action that is comparable to that of standard diclofenac group and 125 mg/kg slide shows a moderate level of cells and mild effect on inflammation.

*Achyranthes aspera* not only reduced the progression of inflammation and arthritis in experimental animals but also improved several symptoms associated with the disease. This study highlights the potential of *Achyranthes aspera* as a reliable treatment for arthritis substantiating the claims of the *plant drugs*.

Discussion {#sec1-4}
==========

In our study, the AEAA exhibited significant anti-arthritic activity in a dose-dependent manner. In the present study, we showed that 250 & 500 mg/kg AEAA could significantly inhibit the progression of rheumatoid arthritis in treating animals. However, standard drug and aqueous extract significantly suppressed the swelling of the paws in the chronic phase, which may be due to the suppression of inflammatory mediator released due to induction of formaldehyde. Though the actual mechanism of suppressing inflammation is not known, it can be correlated with the presence of phenolic compound and flavonoids in suppressing the inflammation and antioxidant activity \[[@ref23]\]. Numerous studies have suggested a role of oxidative stress in the pathogenesis of rheumatoid arthritis \[[@ref24]\].

Therefore; It was assumed that the reported and well-established antioxidant properties of AEAA and its ability to block the COX2 pathway during the progression of inflammation justify the usage of the plant extract in the treatment of rheumatoid arthritis \[[@ref25]\], \[[@ref26]\].

As shown in [Table 2](#T2){ref-type="table"}, assessment of the levels of Hb and ESR provides an excellent and simple tool to measure the anti-arthritic activity \[[@ref27]\] of the target drug. The activities of these parameters were significantly decreased and increased in arthritic rats. These are good indicators, considered to be features of formaldehyde arthritis \[[@ref28]\], \[[@ref29]\]. There was a significant reduction in the paw volume and joint diameter in formaldehyde induced arthritic rats. The Shruti et al. study also revealed cardinal signs of the chronic inflammatory reactions like redness, swelling, arthralgia and immobility of affected joints were significantly less in the drug-treated animal than the negative control \[[@ref30]\] ([Table 3](#T3){ref-type="table"}).

###### 

Effect of aqueous extract of Achyranthesasperaon Hb, ESR & RA factor

  Groups   Treatment & Dose        Hb mg/dl           ESR mm/hr          RA factor
  -------- ----------------------- ------------------ ------------------ -----------
  1        Normal Control          16.8 + 0.35        11.9 + 0.54        Negative
  2        Negative Control        9.58 + 1.04        23.25 + 1.49       Positive
  3        Diclofenac (10 mg/kg)   14.56 + 0.81\*\*   8.96 + .42\*\*     Negative
  4        AEAA 125 mg/kg          10.64 + 0.7^ns^    24.32 + 0.31^ns^   Positive
  5        AEAA 250 mg/kg          12.86 + 0.42\*\*   7.73 + .28\*\*     Negative
  6        AEAA 500 mg/kg          15.71 + 0.28\*\*   10.44 + 0.57\*\*   Negative

###### 

Effect of AEAA on joint swelling (Paw volume)

  Groups   Treatment & Dose        Paw volume in ml   \% inhibition of paw volume on 21^st^ day                                                         
  -------- ----------------------- ------------------ ------------------------------------------- ----------------- ----------------- ----------------- -------
  1        Normal Control          0.04 ± 0.00        0.04 ± 0.00                                 0.05 ± 0.00       0.05 ± 0.00       0.04 ± 0.00       \-
  2        Negative Control        0.26 ± 0.01        0.46 ± 0.01                                 0.55 ± 0.02       0.6 ± 0.02        0.67 ± 0.01       0
  3        Diclofenac (10 mg/kg)   0.20 ± .02\*\*     0.31 ± 0.03\*\*                             0.34 ± 0.01\*\*   0.38 ± 0.02\*\*   0.33 ± 0.01\*\*   36.6
  4        AEAA 125 mg/kg          0.25 ± 0.02^ns^    0.42 ± 0.02^ns^                             0.52 ± 0.02^ns^   0.54 ± 0.02^ns^   0.65 ± 0.01^ns^   10
  5        AEAA 250 mg/kg          0.21 ± 0.00\*\*    0.37 ± 0.01\*\*                             0.38 ± 0.00\*\*   0.42 ± 0.02\*\*   0.38 ± 0.02\*\*   30
  6        AEAA 500 mg/kg          0.18 ± 0.00\*\*    0.30 ± 0.02\*\*                             0.35 ± 0.01\*\*   0.37 ± 0.01\*\*   0.31 ± 0.02\*\*   38.33

Radiographic changes in RA conditions are useful diagnostic measures which indicate the severity of the disease \[[@ref31]\]. Soft tissue swelling is the earlier radiographic sign, whereas prominent radiographic changes like bony erosions and narrowing of joint spaces can be observed only in the development stages (final stages) of arthritis \[[@ref31]\] ([Table 4](#T4){ref-type="table"}).

###### 

Effect of AEAA on the joint diameter

  Groups   Treatment & Dose        Joint diameter in mm   \% inhibition of joint diameter 14^th^ day                                             
  -------- ----------------------- ---------------------- -------------------------------------------- ------------- ------------- ------------- -------
  1        Normal Control          0.42 ± 0.02            0.42 ± 0.02                                  0.42 ± 0.02   0.42 ± 0.01   0.43 ± 0.01   \-
  2        Negative Control        0.55 ± 0.02            0.69 ± 0.01                                  0.77 ± 0.01   0.81 ± 0.02   0.89 ± 0.02   0
  3        Diclofenac (10 mg/kg)   0.40 ± 0.03            0.42 ± 0.02                                  0.51 ± 0.03   0.47 ± 0.02   0.45 ± 0.02   36.61
  4        AEAA 125 mg/kg          0.58 ± 0.02            0.66 ± 0.02                                  0.74 ± 0.01   0.78 ± 0.02   0.86 ± 0.01   3.89
  5        AEAA 250 mg/kg          0.46 ± 0.01            0.48 ± 0.01                                  0.56 ± 0.01   0.55 ± 0.03   0.50 ± 0.03   27.2
  6        AEAA 500 mg/kg          0.38 ± 0.01            0.42 ± 0.02                                  0.49 ± 0.02   0.45 ± 0.02   0.45 ± 0.02   36.36

Radiography result shows that the extract 500 mg/kg of *Achyranthesaspera* prevents joint destruction, swelling & narrowing of joint space. Haematological parameters RA factor results also showed a significant improvement of the arthritic condition. The pathogenesis or reasons for the development of arthritis following injection of formaldehyde are not fully understood. As shown in [Figure 2](#F2){ref-type="fig"}, the treatment groups AEAA 250 mg/kg and 500 mg/kg showed a reduction in pannus formation and bone resorption, joint inflammation with reduced neutrophil infiltration. Formaldehyde induced arthritis is one of the most widely used models as it has been shown to share several clinical features with human arthritis \[[@ref32]\]. Changes in haematological parameters were observed due to arthritic condition \[[@ref33]\].

In conclusion, the present experimental findings of pharmacological, radiological, histological and hematological parameters observed from the current investigation, it is concluded that at the doses of 250mg/kg and 500 mg/kg AEAA possesses potentially useful anti-arthritic activity since it gives a positive result in controlling inflammation in formaldehyde induced arthritis model in rats. The high dose of AEAA reflected highly beneficial and treatment of inflammatory disorders.
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